About Us
  Join the Mailing List

Agenda/ Speakers

Exhibit/ Sponsorship Opportunities


Hotel Accommodation


Conference Handbook


GeneExpression Systems, Inc & Appasani Research Conferences and Educational Institue (ARCEI-US.ORG)
Jontly Presents

Metabolomics-2013 Symposium

Diabetes, Obesity & Cardiovascular Diseases - 2013 Meeting

‘Insulin Resistance to Delivery, Body Weight Regulation & Devices’
‘Molecular Cardiology to Biotherapeutics & Stents’

Date: July 10-11, 2013

Venue:The Joseph B. Martin Conference Center at Harvard Medical School
77 Avenue Louis Pasteur, Boston, MA 02115, USA

Scope of the Meeting:

The purpose and scope of this 'Metabolomics Symposium' is to provide a forum for the discussion of the current state of the art in emerging branches of metabolic diseases that includes diabetes, obesity and cardiovascular diseases to develop appropriate biomarkers, therapeutics and devises for better diagnosis and treatment.

Metabolomics Symposium-2013 on ‘Diabetes, Obesity, Cardiovascular Diseases &Devices’will bring together young and established clinicians, researchers from  academia and industry (with diverse backgrounds in cardiology, cardiac surgery, endocrinology, diabetes, obesity research, stem cell biology, molecular/cellular biology, drug discovery and other aspects of metabolic disease biology), and discuss the clinical and drug/device discovery strategies in form of keynote lectures, invited talks, short oral, and poster presentations. Dedicated time allowed for presentation of posters, viewing the exhibits, to know the available cutting-edge reagent, devises and services in the field. The conference should be interesting for graduate students, postdoctoral fellows, professors, clinicians from academia and scientists, directors, chief scientific officers and chief executive officers from biopharmaindustry, as well as for anyone interested in studying cardiac and metabolic functions and their associated diseases. Authorities in the field selected and invited as presenting speakers.

Needless to say that Diabetes, Obesity and Cardio-vascular diseases are the major devastating metabolic syndromes in the westernized and developing world. This is the most important venue to bring together mix of quality presentations by high-caliber speakers and a place to exhibit lucrative medical devises. In this meeting we will bring latest innovations in the intersection of obesity, diabetes and cardiovascular diseases. Novel genome-wide, proteomics and systems biology approaches will be discussed to understand the molecular signaling events involved in diseased processes, and subsequently develop novel drug targets. This meeting will also highlight the cell therapy approaches using stem cells especially in the treatment of diabetes, vessel repair and regeneration. Most importantly, the latest devices and their applications in the delivery of insulin, glucose monitoring, vascular stents and synthetic valves will be discussed.

The venue is a cutting-edge conference facility located in New Research Building at the Harvard University Medical School nuclear campus (that consists of world-renowned teaching hospitals, Brigham & Women’s Hospital, Children’s Hospital, Beth Israel Deaconess Medical Center, Joslin Diabetes Center, Dana-Farber Cancer Institute, Harvard School of Public Health and close by Massachusetts General Hospital). Best Western, The Inn at the Longwood Medical located few blocks from the venue is arranged for accommodation for this meeting participants.

Expected Maximum Capacity:
Target Audience 100
Total Speaker Presentations: 30
Total Poster Presentations: 15
Total Exhibit Booths: 10

Click Here For Agenda

Wednesday, July 10, 2013
8:00 A.M: Registration Open
9.00 AM – 6.30 PM Scientific Sessions

Thursday, July 11, 2013
8:00 A.M: Registration Open
9.00 AM – 6.30 PM Scientific Sessions
Meeting Concludes

Scientific Organizer:
Krishnarao Appasani, PhD., MBA
Founder & CEO
GeneExpression Systems, Inc
Waltham, MA USA

Diabetes & Obesity (DO)-2013 Meeting
‘Insulin Resistance to Delivery, Body Weight Regulation & Devices’

Cardiovascular Diseases & Devices (CDD)-2013 Meeting
‘Molecular Cardiology to Biotherapeutics & Stents’

Key Sessions
Key Sessions
  • Biology of Diabetes, Obesity & Adipogenesis
  • Detection/Diagnosis using Biomarkers & Imaging
  • Insulin Resistance & Sugar Signaling Mechanisms
  • Novel Insulin Delivery Method
  • Genomic Studies of Complex Metabolic Diseases
  • Multiplex & High throughput Technology Platforms
  • Translational Medicine of Body Weight Regulation
  • Cardiovascular outcome in Diabetes & Obesity
  • Clinical, Etiological and Epidemiological Studies
  • Clinical Trials with Novel Anti-diabetic & Anti-obesity Drug Targets
  • Biology of Angiogenesis & Cardiac Diseases
  • Atherosclerosis, Valve Biology and Pathology
  • Molecular Orchestra of Cholesterol Metabolism
  • Detection/Diagnosis using Biomarkers & Imaging
  • Cardiome & Vascular Signaling Mechanisms
  • Genomics/Proteomics Technology Platforms
  • Translational Medicine of Metabolic Syndromes
  • Cardiovascular Repair, Regeneration & Cell Therapy
  • Coronary Intervention through Stents, Angioplasty & Novel Devices
  • Clinical Trials with Novel Drug Targets

Keynote Speakers:

Peter Libby, MD.
Chief, Division of Cardiovascular Medicine      
Mallinckrodt Professor of Medicine & Director of the Reynolds Cardiovascular Clinical Research Center
Brigham and Women’s Hospital & Harvard Medical School.
Boston, Massachusetts, USA
Title: Cardiovascular Disease: Is Inflammation the missing link??
Evan D. Rosen MD, PhD. 
Associate Professor of Medicine,
Endocrinology, Diabetes, and Metabolism
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, Massachusetts, USA
Title: Epigenetic mechanisms in metabolic health and disease

Other Speakers:

Barbara E. Corkey, PhD.    
Zoltan Kohn Professor of Medicine &
Vice Chair for Research-Obesity Research Center
Boston University School of Medicine
Boston, Massachusetts, USA
Title: Redox Regulation of Metabolic Function

Habib Samady, MD, FACC                                     
Professor of Medicine, Director Interventional Cardiology
& Attending Physician at Emory Clinic
Emory University School of Medicine
Atlanta, Georgia, USA
Title: Predicting Plaque progression in coronary arteries via fluid dynamics

Leonard P. Guarente, PhD.
Novartis Professor of Biology
Massachusetts Institute of Technology
Cambridge, MA, USA
Title: Sirtuins-aging, diseases and circadian control

Da-Zhi Wang, PhD.
Associate Professor of Cardiology
Children's Hospital Boston &
Harvard Medical School
Boston, Massachusetts, USA
Title: microRNAs in the heart

Karin Jandeleit-Dahm, MD, PhD, FRACP
Professor of Medicine & Head of Diabetes and Kidney Disease
Baker IDI Heart and Diabetes Institute
Monash University, Australia & University of Hannover, Germany
Victoria, Australia
Title: Novel targets to treat diabetic complications
Corinth Auld, PhD.                                      
Medical Science Liaison
Mercodia, Inc.
Winston-Salem, NC, USA
Title: Biomarker assays for the detection of metabolic diseases

Zhongdong (John) Huang, PhD.
Associate Director of Cell Biology
Halozyme Therapeutics Inc.
San Diego, CA, USA
Title: Recombinant human hyaluronidase PH20 (rHuPH20) accelerates insulin exposure and does not stimulate inflammation

Gregory D. Lewis, MD.
Associate Professor of Medicine
Harvard Medical School & Associate Director
MGH Cardiopulmonary Exercise Laboratory
Mass General Hospital Heart Center
Boston, Massachusetts, USA
Title: Biomarkers/metabolic signatures for cardiovascular diseases
Donalyn Scheuner, PhD. 
Senior Research Scientist
Diabetes Drug Hunting Team
Eli Lilly & Company
Indianapolis, IN, USA
Title: Stress signaling in beta cell function and metabolic disease

Maria Cecilia Scimia, MD., PhD.
Associate Scientist
Center for Translational Medicine, Temple University
Philadelphia, PA, USA
Title: APJ acts as a dual receptor in cardiac hypertrophy


Jose C. Florez, MD, PhD.
Associate Professor of Medicine
Harvard Medical School & Massachusetts General Hospital & Associate Member of the Broad Institute of MIT & Harvard
Boston, Massachusetts, USA
Title: Genome-wide association studies in the pathophysiology of type 2 diabetes

Dr. Dirk Sartor 
Chief Executive Officer
Cardiolynx Ltd.
Basel, Switzerland
Title: One heart, one life, multiple protection

Yossi Tam, DMD, PhD.
Staff Scientist in Neuroendocrinology Section
Laboratory of Physiologic Studies
NIAAA-National Institutes of Health
Bethesda, Maryland, USA
Title: The peripheral endocannabinoid/CB1 receptor system: A novel therapeutic target for obesity-related leptin resistance

Mannix Auger-Messier, PhD.                                         
Assistant Professor of Medicine
University of Sherbrooke
Sherbrooke, Québec, Canada
Title: The role of DUSP proteins in dilated cardiomyopathy


Mireille J.M. Serlie, MD, PhD.
Professor of Endocrinology and Metabolism
Academic Medical Center-University of Amsterdam
Amsterdam, The Netherlands
Title: The role of serotonin and dopamine in obesity and glucose metabolism

Ting-Ting Hong, MD., PhD.    
Postdoctoral Fellow
Cardiovascular Research Institute
University of California San Francisco
San Francisco, CA, USA
Title: BIN1, an essential cardiac protein that is also a blood-based biomarker of cardiac reserve

Bruce L. Riser, PhD.        
Director, R&D Pharmaceuticals
Baxter Healthcare
McGaw Park, IL, USA
Title: CCN3 based therapy: Novel prevention and treatment in complications of diabetes and obesity

Benjamin S. Maciejewski       
Senior Associate Scientist
CVMED Discovery Innovations
Pfizer Inc. Cambridge, MA, USA
Title: Pharmacological inhibition to examine the role of DGAT1 in rodents and man

Aaron M. Cypess, MD, PhD, MMSc.
Assistant Professor of Medicine
Harvard Medical School &
Assistant Investigator and Staff Physician
Joslin Diabetes Center
Boston, Massachusetts, USA
Title: A new treatment target for obesity and diabetes - brown adipose tissue

Dr. Hana Koutnikova                      
Cardiovascular Health Principal Scientist
Danone Research Company
Palaiseau, France
Title: Functional food as a part of dietary strategy to cardiovascular and metabolic disease management

Takhar Kasumov, PhD.                                           
Staff Member in Gastroenterology &
Assistant Professor of Medicine
Cleveland Clinic & Lerner College of Medicine
Cleveland, OH, USA
Title: Ceramide as a mediator of obesity induced atherosclerosis, Heavy water based metabolic labeling approach

Steven E. Cohen, MD.                                             
Executive Director of External Scientific Affairs
Cardiovascular-Metabolism & Frontiers
Daiichi Sankyo, Inc.  
Edison, NJ 0, USA
Pharma-Academia Collaboration for Enhancing Drug Discovery

Jun Sonoda, PhD.
Scientist of Molecular Biology
Genentech, Inc.
South San Francisco, California, USA
Title: Fat-burning antibody for the treatment of type-2 diabetes 


Neil Poloso, Ph.D.
Principal Scientist of Biological Sciences
Allergan, Inc.
Irvine, CA, USA
Title: The role of prostamides in the regulation of the adipocyte biology

Bridget K. Wagner, PhD.
Director of Pancreatic Cell Biology
Chemical Biology Program
The Broad Institute of Harvard and MIT
Cambridge, Massachusetts, USA
Title: High-throughput screening to identify small-molecule modulators of beta-cell mass

Annie Moisan, PhD.                                     
Post-doctoral Scientist
Cardiovascular & Metabolism Discovery
F. Hoffmann-La Roche
Basel, Switzerland
Title: Pharmacological induction of a brown phenotype in human stem cell-derived adipocytes


Shanta Dhar, PhD.                                       
Assistant Professor of Chemistry
University of Georgia
Athens, GA, USA
Title: HDL-mimicking nanoparticles for atherosclerosis

* Presenting Speaker names, title and times are subject to change.
Host organization, organizer, or scientific committee does not take any kind of responsibility.

Target Audience:

Presidents, CEOs, CSOs and other Management Professionals
Professors, Post docs, and Graduate students from Academia
R & D Scientists from Biotech & Pharma Industry
Clinical Fellows, Residents & Nurses from Health Care Industry
Business Development & Marketing Professionals
Investment, Technology Acquisition Portfolio Managers

Advantages of Attending this Event:

Gain an up-to-date in-depth knowledge of diabetes, obesity & cardio-vascular diseases
Understand the molecular orchestra between diabetes, obesity and other metabolic diseases
Network with senior scientists, management people representing from academia and industry
Develop academic and business collaborations with academicians and pharmaceutical leaders
Exhibit and show case your new products and devices


Exhibitors are welcome to reserve their booth space early!

Please contact if you are interested in speaking in the scientific or Technology workshops of this meeting.

GeneExpression Systems, Inc.
P.O. Box 540170
Waltham, MA 02454 USA
Tel: (781) 891-8181
Fax: (781) 730-0700 or (781) 891-8234
E-mail: Genexpsys@expressgenes.com

Note: Speakers Names, Titles and venue subjected to change beyond our control for which the company is not responsible.

For Oral Presentation Abstracts Due By: June 10, 2013
For Poster Presentation Abstracts Due By: June 30, 2013

Email your abstract (100-200 words in word format) to: Genexpsys@expressgenes.com

GeneExpression Systems™ All Rights Reserved 2013